1. 1656. Impact of Pharmacist Intervention on Antibiotic Prescribing at Hospital Discharge for Community-Acquired Pneumonia, Urinary Tract Infection, and Skin and Soft Tissue Infections. (15th December 2022) Authors: Liu, Elaine; Linder, Kristin E; Dempsey, Casey J; Kuti, Joseph L; Nicolau, David P; Bilinskaya, Anastasia; O'Sullivan, David M; Colmerauer, Jessica L Journal: Open forum infectious diseases Issue: Volume 9:(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Cefiderocol for the Treatment of Adult and Pediatric Patients With Cystic Fibrosis and Achromobacter xylosoxidans Infections. (12th December 2020) Authors: Warner, Nathaniel C; Bartelt, Luther A; Lachiewicz, Anne M; Tompkins, Kathleen M; Miller, Melissa B; Alby, Kevin; Jones, Melissa B; Carr, Amy L; Alexander, Jose; Gainey, Andrew B; Daniels, Robert; Burch, Anna-Kathryn; Brown, David E; Brownstein, Michael J; Cheema, Faiqa; Linder, Kristin E; Shield... Journal: Clinical infectious diseases Issue: Volume 73:Number 7(2021) Page Start: e1754 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Impact of a Pharmacist-Managed Procalcitonin Program on COVID-19 Respiratory Tract Infection Outcomes and Health Care Resource Utilization. (11th September 2022) Authors: Fratoni, Andrew J; Kois, Abigail K; Colmerauer, Jessica L; Linder, Kristin E; Nicolau, David P; Kuti, Joseph L Journal: Open forum infectious diseases Issue: Volume 9:Number 9(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗